Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, International Journal of Pharmaceutics, 2(152), p. 179-183

DOI: 10.1016/s0378-5173(97)00078-1

Elsevier, International Journal of Pharmaceutics, 2(152), p. 185-192

DOI: 10.1016/s0378-5173(97)00079-3

Links

Tools

Export citation

Search in Google Scholar

The human skin blanching assay for in vivo topical corticosteroid assessment

Journal article published in 1997 by John M. Haigh, Eric Meyer, Eric W. Smith, Isadore Kanfer
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The human skin blanching (vasoconstriction) assay for the assessment of topical corticosteroids has been in use for over 30 years, the intensity of the drug-induced blanching being assessed subjectively by eye. Both arms of several male and female volunteers are used for product application and more than one observer is used to estimate the degree of induced blanching. There are, therefore, numerous variables which are inherent in the assay procedure. This investigation consisted of three identical trials performed at 8-week intervals, utilising the same 18 volunteers and the same three observers in an attempt to address the question of reproducibility of the assay. From the results obtained it is clear that the assay methodology is capable of consistently distinguishing, on a rank order basis, between preparations which show similar blanching (chemically-equivalent formulations). The similarity of the results for the three individual trials gives considerable confidence to results produced using this methodology. An experiment designed to test the reproducibility of the blanching scores showed that the observers are capable of producing identical results even though visual observation is highly subjective.